The "environmental protection line" of the pharmaceutical industry is tightened, and the current situation, difficulties and solutions of governance

[Pharmaceutical Network Exhibition Report] Recently, in order to prevent and control environmental pollution, improve environmental quality, protect human health, strengthen the emission control of air pollutants in the pharmaceutical industry, and promote the progress of industrial production technology and pollution control technology, Jiangsu Province announced the air pollution of the pharmaceutical industry.
emission standard (DB 32/4042-2021)
.

It is reported that this document is the integrated ecological and environmental protection standard in the Yangtze River Delta.
The air pollutant emissions of pharmaceutical industrial enterprises in Shanghai, Jiangsu Province, Zhejiang Province and Anhui Province shall be implemented in accordance with the provisions of this document, and the relevant local emission standards for the pharmaceutical industry will no longer be implemented ( Except where there is a special statement)
.

From the perspective of this standard, it mainly includes 8 chapters, which clarify the requirements for organized emission control, unorganized emission control requirements, enterprise boundary monitoring requirements, and pollutant monitoring requirements
.

It can be seen that in recent years, under the background of advocating green environmental protection and sustainable development, the "environmental protection line" of the pharmaceutical industry has been tightened from the national level to the local level
.

This paper mainly analyzes the status quo, difficulties and solutions of environmental protection governance in the pharmaceutical industry
.

 The "environmental protection line" of the pharmaceutical industry is tightened, and the current situation, difficulties and ways of governance are analyzed (Source: Pharmaceutical Network) The current situation of environmental protection management in the pharmaceutical industry In recent years, the scale of China's pharmaceutical market is expanding.
According to statistics, the scale of China's pharmaceutical market has increased from 2015 From around $194.
3 billion to $236.
3 billion in 2019, it is expected to grow to $264.
3 billion by 2021
.

 　　The pharmaceutical industry belongs to the fine chemical industry, with many types of raw materials, large quantities and complex components.
Pharmaceutical companies are prone to produce a large amount of "three wastes" pollution in the production process, namely waste water, waste gas and solid waste pollution
.

Therefore, while the pharmaceutical industry is developing rapidly, pharmaceutical companies are also under enormous environmental pressure
.

Public data shows that at present, the total energy consumption of China's pharmaceutical industry accounts for about 0.
5% of the national total energy consumption, of which the total amount of wastewater discharge accounts for about 2.
5% of the total industrial wastewater discharge, and the total amount of exhaust gas emissions accounts for all industrial waste gas emissions.
About 0.
3% of the total, and the amount of solid waste generated accounts for about 0.
2% of all industrial solid waste
.

And about 80% are caused by the production process of chemical raw materials
.

 　　As the pollution of the three wastes has seriously affected enterprises, society and the ecological environment, in recent years, the state has made more and more efforts to rectify the environmental protection of the pharmaceutical industry.
A large number of pharmaceutical companies have been required to limit production or suspend production for rectification due to substandard environmental protection, which is enough for the entire industry.
A wake-up call
.

According to the public information on environmental protection administrative penalties received by China's pharmaceutical companies in the 10 years from 2011 to 2021, if 2017 is used as the axis, the number of administrative penalties imposed by the environmental protection department on pharmaceutical companies has skyrocketed.
It has declined, but it is still higher than the data from 2014 to 2016, and the data from January to April in 2021 is also significantly higher than that of the whole of 2012
.

It can be seen that China's pharmaceutical companies are still in a high-pressure situation of environmental protection
.

 　　Environmental pressure has also been directly reflected in the number of API and preparation companies
.

According to the "Annual Report on Drug Supervision and Administration Statistics (2020)" issued by the State Food and Drug Administration, the number of API and preparation enterprises in China dropped from 5,065 in 2015 to 4,176 in 2016, a decrease of nearly 20%
.

Behind the decline of this data is not only related to the centralized renewal of GMP certificates in 2015, but also related to the improvement of environmental protection standards faced by API and preparation enterprises
.

For example, the new "Environmental Protection Law", which will be implemented from January 1, 2025, is considered to be a strict regulation of "not environmentally friendly, punishable by bankruptcy" and "not up to standard, do not produce".
The environmental protection pressure of production enterprises has increased sharply, and if they do not solve environmental protection problems, they will face the challenge of survival
.

 　　Where is the problem? How to solve? "Lucid waters and lush mountains are invaluable assets.
" In the context of China's promotion of green development and sustainable development, pharmaceutical companies need to pay attention to the serious practical problems of pharmaceutical environmental protection and put them into action
.

So, what are the main difficulties in the treatment of pollution in the pharmaceutical industry at present? Taking the pharmaceutical wastewater with a high proportion of total discharge as an example, China's pharmaceutical industry is divided into chemical raw material drug manufacturing, chemical drug preparation manufacturing, traditional Chinese medicine decoction pieces processing, Chinese patent medicine production, veterinary drug manufacturing, biological drug manufacturing, and sanitary materials.
7 sub-sectors of medical supplies manufacturing
.

Among them, the production of chemical raw materials accounts for about 80% of the whole industry, and the pollution of this sub-industry is also relatively serious
.

It is understood that the amount of pollutants produced by chemical raw materials is large, and there are many types of pollutants, few single types (low economic availability), biological toxicity, high concentration, basically irregular discharge, discontinuous and unbalanced, and difficult to carry out.
Biochemical treatment
.

 　　"The treatment of high-concentration wastewater has always been a difficult problem for the production and development of chemical raw materials
.

" The industry pointed out that in the national water special survey, the compliance status of pharmaceutical companies is worrying: the number of pharmaceutical companies that can meet the new standard limit of water pollutant discharge in the pharmaceutical industry Quite few, chemical synthesis, fermentation, preparation pharmaceutical wastewater compliance rates were 9%, 12% and 30%
.

According to another survey, most domestic urban sewage treatment plants currently require COD ≤ 300mg/L for wastewater from the pharmaceutical industry.
Even so, there are still some chemical synthesis and fermentation pharmaceutical companies that fail to meet the requirements, and the proportion of chemical synthesis Up to 46%, fermented 16%
.

 　　At present, pharmaceutical wastewater treatment technology mainly includes three kinds of physical method, chemical method and biological method
.

The physical methods include homogenization, dilution, precipitation, floatation, filtration, concentrated crystallization, adsorption, extraction, reverse osmosis,
etc.

Chemical methods include coagulation precipitation, ion exchange, electrodialysis, incineration, and chemical reactions such as neutralization and oxidation
.

Biological laws include aerobic and anaerobic treatment methods such as activated sludge and biological filters
.

According to industry insiders, these technologies have their own advantages, disadvantages and scope of application.
In practical application, they often need to be used in cooperation with each other to deal with pollution control.
The processing technology and process that can undertake the granule load after the product output changes
.

 　　In order to better meet the discharge requirements of pharmaceutical wastewater, some industrial enterprises are also innovating and exploring pharmaceutical wastewater treatment technology
.

For example, the EP-Kaisen electrochemical oxidation technology of Hebei Fengyuan Environmental Protection Technology Co.
, Ltd.
uses the electrochemical oxidation reaction in the electrolysis process in a specific electrochemical reactor under the action of an external electric field to efficiently degrade COD in sewage.
, ammonia nitrogen, chromaticity, cyanide, phenols, etc.
, do not cause secondary pollution, and have great advantages in the advanced treatment upgrading and upgrading projects of various industrial parks and enterprises, which can ensure that COD, ammonia nitrogen, ammonia nitrogen, ammonia nitrogen, ammonia nitrogen, ammonia nitrogen, ammonia nitrogen, ammonia nitrogen, ammonia nitrogen, ammonia nitrogen, ammonia nitrogen, ammonia nitrogen, ammonia nitrogen, ammonia nitrogen, ammonia nitrogen, ammonia nitrogen, chromaticity, cyanide, phenols, etc.
Indicators such as chromaticity meet the emission standards
.

 　　Another reason for the difficulty in treating wastewater from chemical API production is that companies cannot afford large investment and operating costs, resulting in the problem of not meeting the standards for a period of time
.

It is understood that China's bulk API production profit is meager, and the cost of pollution control accounts for 4%-30% of the production cost
.

This situation often puts pressure on companies to deal with the cost of environmental protection
.

 　　From the experience of people who have been engaged in environmental protection management in the pharmaceutical industry for many years, the key to the treatment of waste gas and wastewater in the pharmaceutical industry at present is the issue of economic cost and applicability
.

The person said that from the domestic situation, the technology of wastewater and waste gas treatment in China has developed rapidly in recent years, so the difficulty of environmental protection treatment of pharmaceuticals is not only a technical problem, but also many enterprises cannot afford it economically.
The gas and other by-products generated during the treatment process cannot be reused as resources
.

 　　For environmental protection, achieving low cost and high efficiency is the solution
.

On the one hand, realize resource recycling
.

For example, in early 2021, ten ministries and commissions including China's National Development and Reform Commission issued the "Guiding Opinions on Promoting the Resource Utilization of Sewage Water".
Under the general policy, the entire thinking of pharmaceutical companies on environmental protection needs to be changed, not limited to the original standardization and popularization.
, but to achieve ultra-purification and resource utilization, which also releases a signal of high-value resource recovery in sewage, requiring enterprises to work on process improvement and cleaner production
.

It is reported that the key technology of three wastes pro-oxygen pyrolysis catalytic purification of Nanjing Zihuan Engineering Technology Research Institute Co.
, Ltd.
is suitable for the treatment and resource recycling of VOCs, organic wastewater, waste liquid and waste salt in the pharmaceutical industry
.

The technology creatively proposes the idea of ​​treating waste according to the molecular structure of waste, and is used for deep purification and resources of common "three wastes" such as organic waste gas, organic waste liquid, distillation residue, salt-containing waste water, waste salt, and organic solid waste.

change .

 　　On the other hand, there is a need to reduce processing costs
.

For example, it can be considered to introduce technologies in other fields, including the structure of some catalyst research and development equipment, the introduction of computer software, and the massive intervention of software for simulating flow regimes and simulating reaction conditions, so as to optimize the reactor, increase efficiency, and reduce processing costs.
Solve the problem of waste water and waste gas faced by the pharmaceutical industry
.

 　　In order to better solve environmental problems and strengthen environmental pollution control, the 2021 World Environmental Protection Conference [International Environmental Protection Exhibition] will be held at the Shanghai National Convention and Exhibition Center from June 2 to 4
.

This exhibition covers 8 major environmental pollution control fields, including comprehensive treatment, water, atmosphere, smart environmental protection, environmental monitoring, resource regeneration, soil, and noise.
It has gathered more than 1,600 environmental companies, and has an exhibition area of ​​150,000 square meters.
It has become a large-scale exhibition.
World Environmental Expo platform
.

The online environmental technology exhibition hall launched at the same time on the platform will show you the new technologies of environmental protection engineering with application value in the fields of wastewater treatment, waste gas treatment, solid waste disposal, and environmental restoration
.